Serum EGFR and Serum HER-2/neu Are Useful Predictive and Prognostic Markers in Metastatic Breast Cancer Patients Treated With Metronomic Chemotherapy

M. Cristofanilli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Serum EGFR and Serum HER-2/neu Are Useful Predictive and Prognostic Markers in Metastatic Breast Cancer Patients Treated With Metronomic Chemotherapy'. Together they form a unique fingerprint.